News

En esta información se explica qué esperar durante el tratamiento de su hijo con naxitamab. Se explica qué hacer y qué esperar antes, durante y después de sus citas de tratamiento.
En esta información se explica su Lista de verificación de objetivos para el alta. Además, se explica cómo utilizarla en su teléfono inteligente o tableta.
Get the latest research updates from investigators across MSK on why so many young adults are getting cancers.
View the Naama Aviram Lab page for Evolution of Immunity Across Domains of Life.
Memorial Sloan Kettering Cancer Center (MSK) and United Healthcare (UHC) today announced a new, multi-year agreement that ensures continued in-network access to MSK for UHC’s commercial members. As a ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK), the University of California, San Francisco (UCSF), and University of California, Berkeley (UC Berkeley) have developed an artificial ...
Researchers from Memorial Sloan Kettering Cancer Center (MSK) reported important advances in the treatment of lung cancer at the annual meeting of the American Society of Clinical Oncology (ASCO), ...
Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN) and Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer center, today announced a collaboration harnessing the ...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient’s own immune T cells and engineering them to recognize specific targets ...
Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups.
Lung cancer is the second-most common cancer and remains the leading cause of cancer death in the United States. But a variety of new treatments, many of them developed or tested at Memorial Sloan ...